R-ESHAP as salvage therapy in patients with relapsed or refractory diffuse large B-cell lymphoma: A prospective phase II study.
K. Xue
No relevant relationships to disclose
B. Y. Wang
No relevant relationships to disclose
X. Hong
No relevant relationships to disclose
Y. Guo
No relevant relationships to disclose